Analytical Data
-
Gene name
KIF26A
- Application
-
Alternative Names
DKFZP434N178; FLJ22753; KI26A_HUMAN; KIAA1236; KIF 26A; KIF26A; KIF26A variant protein; Kinesin family member 26A; Kinesin like protein KIF26A; Kinesin-like protein KIF26A
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9ULI4
-
Expression Region
1-203aa
-
AA Sequence
MSESGAASPGARTRSLKSPKKRATGLQRRRLIPAPLPDTTALGRKPSLPGQWVDLPPPLAGSLKEPFEIKVYEIDDVERLQRPRPTPREAPTQGLACVSTRLRLAERRQQRLREVQAKHKHLCEELAETQGRLMLEPGRWLEQFEVDPELEPESAEYLAALERATAALEQCVNLCKAHVMMVTCFDISVAASAAIPGPQEVDV
-
Molecular Weight
48.07 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KIF26A, a member of the kinesin superfamily of motor proteins, has garnered increasing attention in recent years due to its potential role in intracellular transport and development. The protein is primarily expressed in the brain and various tissues, suggesting its involvement in critical physiological processes. Initial studies have implicated KIF26A in neuronal development, particularly in the guidance of axonal growth, which is essential for proper neural circuit formation. Furthermore, its dysfunction has been associated with multiple neurodevelopmental disorders. Recent advancements in recombinant protein techniques have allowed for the detailed study of KIF26A's structure and function. By expressing and purifying KIF26A as a recombinant protein, researchers can investigate its mechanistic roles in cellular transport, interaction with various cargoes, and its regulatory pathways. Understanding KIF26A’s specific functions and interactions is essential for elucidating its biological relevance and potential links to disease. The exploration of KIF26A as a therapeutic target may offer new avenues in the treatment of neurodevelopmental disorders and related conditions, making it a significant focus in current molecular and cellular biology research.
